跳至主要内容
临床试验/JPRN-jRCTs031180403
JPRN-jRCTs031180403进行中(未招募)2 期

A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with pathologically confirmed stage IIIA-N2 squamous-cell non-small cell lung cancer.

Suzuki Kenji0 个研究点目标入组 45 人开始时间: 2019年3月20日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
Suzuki Kenji
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • (1) Histologically or cytologically proven squamous cel carcinoma of the lung, diagnosed using specimen material
  • (2) Stage IIIA- pathologically proven N2 disease
  • (3) Without previously treatment for lung cancer
  • (4) 20 years or more , 75 years or less
  • (5) ECOG PS 0-1
  • (6) Expected FEV 1.0 > 800ml after lung resection , SpO2 (Room air) >95%
  • (7) Adequate organ function
  • (8) Written informed consent

排除标准

  • (1) Uncontrollable systemic disease (hyper tension, diabetes mellitus etc.)
  • (2) Under administration of flucytosine
  • (3) History of active infection
  • (4) Hepatitis Bs antigen positive
  • (5) History of severe heart disease
  • (6) Traumatic fracture of un recovery
  • (7) Severe diarrhea
  • (8) Severe drug allergy
  • (9) Investigational new drug or the unapproved drug is administered
  • (10) Interstitial pneumonia or pulmonary fibrosis detectable on chest CT
  • (11) History of active double cancer
  • (12) History of pregnancy or lactation
  • (13) Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator

研究者

发起方
Suzuki Kenji

相似试验